ACM
RXDX

Aquatic Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Aquatic Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,600
Closed -$834K – 1876
2022
Q4 		$834K Buy
+7,600
New +$834K 0.06% 363